Searchable abstracts of presentations at key conferences in endocrinology

ea0093p14 | Guided Poster Tour 2: Miscellaneous | EYES2023

Assessment of knowledge and awareness of disease in patients with diabetes

Vasiljevic Luka , Sparavalo Rada

Introduction and objective: The research was conducted with the aim of highlighting the awareness and understanding of the disease among diabetic patients.Methods: The study included 85 patients with type 2 diabetes, aged 40+ years old, who had been monitoring their blood glucose levels and HbA1c levels in the previous 4 months. Patients were presented a questionnaire with 5 questions about diabetes. The patients’ responses were classified and expre...

ea0035p399 | Diabetes (epidemiology, pathophysiology) | ECE2014

Evaluation of the approach to diabetic patients before the first admission to diabetologist: Is there a room for the improvement?

Maric Andreja , Poljak Bozidar , Igrec Irena , Struc Luka , Gradiser Marina

Introduction: Diabetes mellitus (DM) is a chronic disease that can be largely managed in the primary care system.Aim: We analysed medical records of diabetic patients (pts) treated in Center for diabetes in our institution, during 1 year, determining the quality of care.Material and methods: The search was focused on pts at first admission to the diabetologist. Analysis included demographic and clinical characteristics of pts, meta...

ea0081oc5.2 | Oral Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Once-weekly semaglutide delays a late phase gastric emptying of solid meal measured by repeated scintigraphic imaging in obese women with PCOS

Jensterle Mojca , Ferjan Simona , Lezaic Luka , Socan Aljaz , Zaletel Katja , Janez Andrej

Background: GLP-1 agonism have the potential to affect gastric emptying (GE), yet the reports for subcutaneous semaglutide, currently the most effective GLP-1 RA approved for weight management, remain inconclusive. It has been demonstrated that semaglutide either had no effect on GE or it delayed GE only within the first hour, without late phase retention. Notably, those conclusions were made by an indirect method of estimation of GE through ingestion, absorption and determina...

ea0090p583 | Calcium and Bone | ECE2023

Impact of Zoledronate or Denosumab on Bone-related Biochemical Parameters in Osteoporotic Postmenopausal Women with Primary Hyperparathyroidism

Mlekus Kozamernik Katarina , Ležaić Luka , Hočevar Marko , Kocjan Tomaž

Introduction: Antiresorptive treatment can preserve bone mineral density (BMD) in patients with primary hyperparathyroidism (PHPT) when surgery is not feasible or desired. We aimed to compare the impact of zoledronate vs denosumab on bone-related biochemical parameters in this population.Methods: We analyzed preliminary data from our ongoing randomized trial on osteoporotic postmenopausal women with PHPT who are being treated either with zoledronate 5 mg...

ea0035oc3.3 | Neuroendocrinology & Signalling | ECE2014

Evidence for interaction between the β2-adrenergic and the insulin receptor

Mandic Maja , Drinovec Luka , Glisic Sanja , Veljkovic Nevena , Nohr Jane , Vrecl Milka

Functional interplay between different classes of receptors has emerged as a notable factor of cellular response in health and disease. One of the most prominent examples of cross-talk involves the regulation of glucose metabolism, a major regulatory function under the influence of both insulin receptor (IR) and β2-adrenergic receptor (β2-AR) representing the receptor tyrosine kinases (RTKs) and the seven transmembrane receptors (7TMRs) respecti...

ea0032p398 | Diabetes | ECE2013

Glycemic and lipid profile in patients with acute pancreatitis

Maric Andreja , Bel Masa , Igrec Miljenka , Kovacic Mihajlo , Marodi Ivana , Kuzat Luka , Poljak Bozidar , Gradiser Marina

Introduction: Early hyperglycemia in acute pancreatitis (AP) is prognostic sign of severe attack. Elevated lipid levels are one of the major risk factors for AP. The objective of this work was to evaluate the glycaemic and lipid profile in patients (pts) with acute pancreatitis, treated in our institution.Methods: A total of sixty nine pts with AP were admitted to a Department of Internal medicine, from January to December 2012.At ...

ea0094p89 | Neuroendocrinology and Pituitary | SFEBES2023

Desmopressin prescription safety in adult inpatients: Experience from a quality improvement project

Fahad Arshad Muhammad , Solanki Sam , Karunanayaka Madushani , Dancyger-Stevens Luka , Munir Alia

Background: Cranial Diabetes Insipidus (CDI) or Arginine-Vasopressin Deficiency (AVP-D) is a potentially life-threatening condition requiring treatment with desmopressin. Omission or delay in desmopressin can result in serious patient harm.Aims: Evaluation of desmopressin prescription/administration practice and implementation of an action plan to improve patient safety.Methods: Re...

ea0099p437 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenocortical activity in patients with vasovagal syncope

Bačkorova Barbora , Lazurova Zora , Lukačova Monika , Mitro Peter , Lazurova Ivica

Background: Syncope is a transient loss of consciousness resulting from cerebral hypoperfusion. Despite the extensive efforts by the scientific community over decades, the pathophysiology remains unclear. Although syncope itself is a reversible, short-lasting, benign condition, it negatively impacts quality of life. Vasovagal syncope (VVS) is a form of orthostatic intolerance (OI). Its clinical signs such as dizziness and hypotension may mimic symptoms of adrenal insufficiency...

ea0099p247 | Calcium and Bone | ECE2024

More potent antiresorptive effect of denosumab versus zoledronate in osteoporotic postmenopausal women with primary hyperparathyroidism

Kozamernik Katarina Mlekus , Ležaić Luka , Hočevar Marko , Kocjan Tomaž

Introduction: Primary hyperparathyroidism (PHPT) is a state of increased bone turnover that can result in secondary osteoporosis. Antiresorptive treatment can be used to preserve bone mineral density (BMD). We compared the impact of zoledronate and denosumab on bone-related biochemical parameters.Methods: We analyzed interim data from our ongoing randomized trial on osteoporotic postmenopausal women with PHPT who are being treated with either zoledronate...

ea0081ep286 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Age-related changes in proinsulin processing in non-diabetic individuals

Vaňkova Marketa , Vejražkova Daniela , Lukašova Petra , Včelak Josef , Bendlova Běla

Introduction: To understand the pathological changes associated with glucose homeostasis in old age, it is necessary to know the natural changes in the processing of proinsulin into mature insulin. Surprisingly, while there is abundant information about insulin function in diabetics, the situation in healthy adults and old humans was rarely examined.The study aimed: To determine how the proinsulin secretion in individuals with normal glucose tolerance ch...